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Letters to the Editor 
Dear Editor 
Atypical localization of pulmonary i&hates in 
sarcoidosis 
Sarcoidosis is a systemic granulomatous disease of 
unknown aetiology that most commonly involves the 
lung (1). More than 90% of patients with sarcoidosis 
will show abnormalities on chest X-ray films some- 
time during the course of their disease (1). The com- 
mon roentgenographic presentations of pulmonary 
sarcoidosis are well known, and include lymph node 
enlargement and/or diffuse, parenchymal interstitial 
infiltrates (2). We report an unusual case of thoracic 
sarcoidosis which showed bilateral, peripheral, 
patchy parenchymal infiltrates of the lung, without 
any mediastinal or hilar lymphadenopathy. 
A 27-year-old female patient was admitted to our 
outpatient clinic with an abnormal chest X-ray film 
which had been taken during a routine check-up 
examination. They started anti-tuberculosis therapy 
with three drugs in the other hospital to which she 
had referred before. When there was no change in the 
chest X-ray film after 2 months of treatment, she 
referred to our department for further examination. 
Physical examination revealed normal findings. 
Chest radiograph showed bilateral, diffuse, patchy 
infiltrations being more prominent in the peripheral 
regions. Smear and culture of the sputum were 
negative for acid-fast bacilli. Erthyrocyte sedi- 
mentation rate, complete blood count (including 
differential count of the white blood cells), serum 
electrolyte concentrations and kidney and liver 
function tests were in normal ranges. ACE concen- 
tration was 5 Ul ~ ‘. Arterial blood gases revealed; 
pH 7.43, PCO, 35 mmHg, PO, 80 mmHg and HCO, 
24 mEq1 - ‘. Pulmonary function tests showed mild 
small-airway obstruction, restriction and decrease 
in the diffusion capacity of the lung. Computed 
tomography of the thorax disclosed diffuse, bilateral, 
multiple infiltrative lesions being more prominent at 
the periphery of the lung. Gallium scanning of the 
lung was normal. Thoracotomy was performed to 
obtain a specimen, which on examination revealed 
granulomatous disease consistent with sarcoidosis. 
We started to treat the patient with corticosteroid 
drugs, and noticed improvement in her chest X-ray 
films from the end of the first month of therapy, 
at the monthly follow-up visits. She developed 
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spontaneous pneumothorax on the third month of 
treatment, for which she has been treated in our 
radiology department by tube drainage using a 
Heimleich valve. She recovered in 24 h and is still 
receiving tapered doses of corticosteroid therapy. 
Isolated, peripheral parenchymal infiltrates in the 
lung are a rare initial manifestation of sarcoidosis (3). 
Glazer et al. (1) mentioned eight patients having 
infiltrates of this type, all of whom had hilar or 
mediastinal adenopathy. Scott and Pinstein (4) 
described a case with a chest X-ray film which 
showed mainly peripheral pulmonary infiltrates 
without any mediastinal or hilar adenopathy. Also, 
Judson et al. (3) presented a patient with chest 
CT scans showing isolated, peripheral pulmonary 
infiltrates. As a result, to our knowledge, our case 
is the third sarcoidosis case in which the chest 
CT scans showed isolated, peripheral pulmonary 
infiltrates. 
G. KISACIK, L. Cap~ij, Y. KARAKOCA AND 
A. U. DEMIR 
Department of Chest Diseases, 
Hacettepe University Hospital 
Ankara, Turkey 
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Dear Editor 
Necrotizing vasculitis and exacerbation of psoriasis 
after granulocyte colony-stimulating factor for small 
cell lung carcinoma 
Granulocyte colony-stimulating factor (G-CSF) is 
widely used as an adjunct to chemotherapy in 
patients with small cell lung cancer (1). We report 
on a case simultaneously presenting two cutaneous 
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complications, necrotizing vasculitis and exacer- 
bation of a pre-existing psoriasis, after use of G-CSF 
for treatment of a small cell lung cancer. 
A 45year-old woman was treated for a limited 
small cell lung cancer with a chemotherapy regimen 
consisting of cyclophosphamide (1 g m ~ 2), doxo- 
rubicin (50 mg m ~ ‘), cisplatin (100 mg m - 2), and 
etoposide (200 mg mp2). Because the patient had 
febrile neutropenia after the first course of chemo- 
therapy, she was treated with 3OOpg day-’ of 
G-CSF subcutaneously on days 3-10 following the 
end of the second course of chemotherapy. Four days 
later, she developed palpable purpuric lesions on the 
legs characteristic of a necrotizing vasculitis, and we 
observed exacerbation of psoriasis over thorax and 
legs. No biopsy was done as clinical aspects were 
rather characteristic. 
There were no antibodies detected for nuclear 
cytoplasm antigens, hepatitis B and C viruses or 
human immunodefiency virus. Cryoglobulinemia and 
proteinuria were absent. The leucocyte count was 
3.5 x lo9 1~ ’ with 2.8 x lo9 l- ’ neutrophils; plate- 
lets were 211 x lo9 I- r. Treatment with topical cor- 
ticosteroid resolved psoriasis within 10 days, and 
purpuric lesions disappeared in about the same time. 
Considering the relative severity of the cutaneous 
lesions, the patient did not receive further G-CSF. 
Two additional courses with cisplatin and etoposide 
were administered simultaneously with thoracic 
radiotherapy, without recurrence of the cutaneous 
adverse effects. 
Large reports of G-CSF treated patients with 
small cell lung cancer have been reported without 
cutaneous adverse effects (1,2). However, one patient 
with small cell lung cancer developed pyoderma 
gangraenosum during G-CSF therapy, and another 
patient showed necrotizing vasculitis with 
granulocyte-macrophage stimulating factor (3,4). Six 
other cases of cutaneous vasculitis have been 
reviewed in patients with various tumours, treated 
with leucocyte colony-stimulating factors. The erup- 
tions are unrelated to the primary diseases and 
developed after 1 or 2 weeks of therapy. It is inter- 
esting that exacerbation of psoriasis has been noted 
in a patient with aplastic anemia subsequent to 
granulocyte macrophage-stimulating factor (5). To 
our knowledge, our case report is the first with both 
vasculitis and psoriasis. The mechanisms by which 
G-CSF exacerbate pre-existing psoriasis or induce 
vasculitis remain unknown. Various cytokines may 
be an indirect cause (tumour necrosis factor, 
interleukin-1) (6). We conclude that patients and 
physicians should be aware of the development 
of various inflammatory processes during G-CSF 
treatment. Patients with pre-existing psoriasis should 
be treated with caution, while receiving G-CSF. 
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Dear Editor 
Gallbladder wall thickening as a sign of pulmonary 
embolism 
Alvarez-Sala et al. described a patient with acute 
pulmonary embolism, in whom thickening of the 
gallbladder wall was shown by abdominal sonogra- 
phy (1). The authors suggest that this could be an 
initial sign of increased cystic and systemic venous 
hypertension, due to right cardiac failure, and hence 
to acute pulmonary embolism. The validity of the 
sign, however, is not established, since other cases 
have not been reported (2). We wish to report a case 
of acute pulmonary embolism we have observed, in 
which this sign was present. 
A 92-year-old woman was admitted because of 
vomiting and tachycardia of several days duration. 
She denied dyspnoea and thoracic or abdominal 
pain. The remaining history was unremarkable. 
Blood pressure was 120/90 mmHg, heart rate was 
